Effect of Pioglitazone on Testosterone in Eugonadal Men With Type 2 Diabetes Mellitus - A Pilot Study

Efficacy vs Placebo as Initial Combination Therapy With Pioglitazone

NCT00641043 ·Status: COMPLETED ·Phase: PHASE3

Does Pioglitazone Increase the Production of 15-EPI-Lipoxin A4?

NCT01040819 ·Status: COMPLETED ·Phase: PHASE4

Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart Disease

NCT00479986 ·Status: COMPLETED ·Phase: PHASE4

Comparison of the Efficacy and Safety Between Pioglitazone and Placebo Added to Combination Therapy in Type 2 Diabetes

NCT00991055 ·Status: UNKNOWN ·Phase: PHASE4

Metabolic Effects of Pioglitazone in Type II Diabetic Patients Previously Treated With Insulin

NCT00576784 ·Status: COMPLETED ·Phase: PHASE4

Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes

NCT00754403 ·Status: COMPLETED ·Phase: PHASE4

Role of Pioglitazone in Preventing Diabetes

NCT00276497 ·Status: COMPLETED ·Phase: PHASE1

Efficacy of Pioglitazone and Insulin in Treating Subjects With Type 2 Diabetes Mellitus and Renal Failure.

NCT00770640 ·Status: COMPLETED ·Phase: PHASE2

Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes

NCT01124656 ·Status: TERMINATED ·Phase: PHASE3

Effects of Rosiglitazone on Bone in Postmenopausal Diabetic Women

NCT00440375 ·Status: COMPLETED ·Phase: PHASE4

Cohort Study of Pioglitazone and Cancer Incidence in Participants With Diabetes Mellitus.

NCT02958956 ·Status: COMPLETED

Pioglitazone Incretin Study

NCT00656864 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Efficacy and Safety of Pioglitazone 15mg or 30mg Add-on in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin and Dapagliflozin

NCT04885712 ·Status: COMPLETED ·Phase: PHASE3

Pioglitazone vs. Insulin Glargine in the Treatment of Secondary Drug Failure in Type 2 Diabetes

NCT00609856 ·Status: COMPLETED ·Phase: PHASE4

Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes

NCT05629806 ·Status: UNKNOWN ·Phase: PHASE3

Efficacy and Safety Study of Pioglitazone Combined With Metformin on Metabolic Syndrome in Subjects With Type 2 Diabetes

NCT00772174 ·Status: COMPLETED ·Phase: PHASE3

Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?

NCT06922656 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Randomized, Double-Blind, Comparator- and Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability and Efficacy of Three Dose Levels of MSDC-0602 in Type 2 Diabetic Patients

NCT01280695 ·Status: COMPLETED ·Phase: PHASE2

Pioglitazone Add-on Study in Patients With Type 2 Diabetes Mellitus

NCT00086502 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Dutogliptin in Patients With Type 2 Diabetes Mellitus (T2DM) on Background Therapy With Pioglitazone

NCT00970424 ·Status: TERMINATED ·Phase: PHASE3

Efficacy of Pioglitazone and Metformin on Cardiovascular Risk in Subjects With Insulin-Treated Type 2 Diabetes Mellitus.

NCT00770445 ·Status: COMPLETED ·Phase: PHASE4

Effect of Thiazolidinedione Treatment Vascular Risk Markers

NCT00571506 ·Status: COMPLETED ·Phase: PHASE4

Effect of Pioglitazone on Ambulatory Blood Pressure

NCT00328393 ·Status: COMPLETED ·Phase: PHASE3

SGLT2i, Pioglitazone, and Ketone Production in T2D

NCT07053319 ·Status: RECRUITING ·Phase: PHASE1

Efficacy of Pioglitazone on Microcirculation in Type 2 Diabetes Patients Treated With Insulin

NCT00676260 ·Status: COMPLETED ·Phase: PHASE2